Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

• Collection of clinical data, health and family histories by survey [ Time Frame: baseline enrollment, 6 months, 12 months ] [ Designated as safety issue: No ]
• Collection of blood and/or tissue, fecal and oral specimens [ Time Frame: baseline ] [ Designated as safety issue: No ]
• Collection of information regarding food preparation and intake by survey [ Time Frame: baseline ] [ Designated as safety issue: No ]

• Collection of clinical data, health and family histories by survey [ Designated as safety issue: No ]
• Collection of blood and/or tissue, fecal and oral specimens [ Designated as safety issue: No ]
• Collection of information regarding food preparation and intake by survey [ Designated as safety issue: No ]
• Establish a medical information and biospecimen bank for future research studies [ Designated as safety issue: No ]

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.

PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

OBJECTIVES:

Primary

• To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies.
• To collect information regarding food preparation and intake in these patients.

Secondary

• To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer.
• To investigate genes or substances that increase susceptibility of developing pancreatic conditions.
• To find agents that may help prevent, treat, or cure these conditions.
• To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.

OUTLINE: This is a multicenter study.

Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.

Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.

Pancreas disease patients

• Islet Cell Tumor
• Pancreatic Cancer
• Pancreatic Disease

• Other: medical chart review
  baseline, 12 month and 36 months
• Other: survey administration
  baseline, 6 month, 12 month
• Other: biospecimen collection
  baseline

DISEASE CHARACTERISTICS:

• Diagnosis or suspicion of at least one of the following:

  • Pancreatic cancer
  • Pancreatic mass
  • Islet cell tumor
  • Intraductal papillary mucinous neoplasms (IPMN)
  • Hereditary pancreatitis

PATIENT CHARACTERISTICS:

• Able to understand and read English
• Mentally competent and able to provide informed consent
• Has not donated blood within the past 8 weeks

PRIOR CONCURRENT THERAPY:

• At least 7 days since prior blood transfusion
• At least 7 days since prior surgery